Colistin sulfate/Tobramycin/Nystatin

硫酸多粘菌素E/妥布霉素/制霉菌素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameColistin sulfate/Tobramycin/Nystatin
Drug Alias NameSDD Oral Paste（The George Institute For Global Health）
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibioticsSmall molecules > Heterocyclic drugs
Mechanisms of Action30S ribosomal subunit inhibitorsErgosterol binders
Targets30S ribosomal subunitErgosterol
Therapy Area/IndicationsCritical IllnessShock, SepticSepsis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaAustraliaUnited Kingdom
CombinationsYes Colistin sulfateTobramycinNystatin
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe George Institute For Global Health
China Registration ClassN/A

Develop Information

Active CompaniesThe George Institute For Global Health
Inactive CompaniesN/A
Active IndicationsCritical IllnessShock, SepticSepsis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A